Bank of America’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.78B | Sell |
19,978,936
-3,142,684
| -14% | -$440M | 0.2% | 98 |
|
|
2025
Q4 | $2.84B | Buy |
23,121,620
+2,982,788
| +15% | +$362M | 0.21% | 100 |
|
|
2025
Q3 | $2.24B | Buy |
20,138,832
+1,156,528
| +6% | +$131M | 0.15% | 133 |
|
|
2025
Q2 | $2.1B | Buy |
18,982,304
+629,467
| +3% | +$67M | 0.15% | 134 |
|
|
2025
Q1 | $2.06B | Buy |
18,352,837
+635,157
| +4% | +$65.5M | 0.17% | 123 |
|
|
2024
Q4 | $1.64B | Buy |
17,717,680
+10,487,673
| +145% | +$944M | 0.14% | 148 |
|
|
2024
Q3 | $606M | Buy |
7,230,007
+554,777
| +8% | +$42.3M | 0.05% | 363 |
|
|
2024
Q2 | $458M | Buy |
6,675,230
+58,754
| +0.9% | +$3.92M | 0.04% | 404 |
|
|
2024
Q1 | $485M | Buy |
6,616,476
+154,019
| +2% | +$11.8M | 0.04% | 383 |
|
|
2023
Q4 | $524M | Buy |
6,462,457
+1,084,853
| +20% | +$84.4M | 0.05% | 331 |
|
|
2023
Q3 | $403M | Sell |
5,377,604
-1,728
| -0% | -$133K | 0.04% | 377 |
|
|
2023
Q2 | $415M | Sell |
5,379,332
-2,319,931
| -30% | -$185M | 0.04% | 365 |
|
|
2023
Q1 | $639M | Buy |
7,699,263
+115,510
| +2% | +$9.57M | 0.07% | 270 |
|
|
2022
Q4 | $651M | Buy |
7,583,753
+601,855
| +9% | +$47.7M | 0.07% | 263 |
|
|
2022
Q3 | $431M | Sell |
6,981,898
-383,246
| -5% | -$24.2M | 0.05% | 335 |
|
|
2022
Q2 | $455M | Sell |
7,365,144
-405,094
| -5% | -$25.1M | 0.05% | 332 |
|
|
2022
Q1 | $462M | Buy |
7,770,238
+762,250
| +11% | +$48.7M | 0.04% | 363 |
|
|
2021
Q4 | $509M | Sell |
7,007,988
-654,527
| -9% | -$45.1M | 0.05% | 346 |
|
|
2021
Q3 | $535M | Buy |
7,662,515
+528,382
| +7% | +$37.1M | 0.06% | 320 |
|
|
2021
Q2 | $491M | Sell |
7,134,133
-872,099
| -11% | -$58.2M | 0.05% | 342 |
|
|
2021
Q1 | $517M | Buy |
8,006,232
+2,672,690
| +50% | +$172M | 0.06% | 305 |
|
|
2020
Q4 | $311M | Sell |
5,333,542
-2,027,468
| -28% | -$122M | 0.04% | 391 |
|
|
2020
Q3 | $465M | Buy |
7,361,010
+6,637
| +0.1% | +$460K | 0.06% | 268 |
|
|
2020
Q2 | $566M | Sell |
7,354,373
-927,368
| -11% | -$71.1M | 0.09% | 226 |
|
|
2020
Q1 | $619M | Sell |
8,281,741
-213,705
| -3% | -$14.8M | 0.11% | 186 |
|
|
2019
Q4 | $552M | Buy |
8,495,446
+1,253,300
| +17% | +$81.6M | 0.08% | 250 |
|
|
2019
Q3 | $459M | Buy |
7,242,146
+739,642
| +11% | +$48.4M | 0.07% | 280 |
|
|
2019
Q2 | $439M | Sell |
6,502,504
-454,136
| -7% | -$29.9M | 0.07% | 287 |
|
|
2019
Q1 | $452M | Buy |
6,956,640
+30,261
| +0.4% | +$2.01M | 0.07% | 273 |
|
|
2018
Q4 | $433M | Sell |
6,926,379
-909,038
| -12% | -$63.5M | 0.08% | 263 |
|
|
2018
Q3 | $605M | Sell |
7,835,417
-37,202
| -0.5% | -$2.81M | 0.09% | 222 |
|
|
2018
Q2 | $558M | Buy |
7,872,619
+46,709
| +0.6% | +$3.3M | 0.09% | 230 |
|
|
2018
Q1 | $590M | Sell |
7,825,910
-7,708
| -0.1% | -$613K | 0.1% | 204 |
|
|
2017
Q4 | $561M | Sell |
7,833,618
-2,560,857
| -25% | -$194M | 0.09% | 230 |
|
|
2017
Q3 | $842M | Buy |
10,394,475
+1,375,852
| +15% | +$105M | 0.13% | 165 |
|
|
2017
Q2 | $638M | Sell |
9,018,623
-1,066,504
| -11% | -$71M | 0.13% | 182 |
|
|
2017
Q1 | $685M | Sell |
10,085,127
-392,122
| -4% | -$27.6M | 0.14% | 162 |
|
|
2016
Q4 | $750M | Sell |
10,477,249
-279,151
| -3% | -$20.7M | 0.16% | 149 |
|
|
2016
Q3 | $851M | Sell |
10,756,400
-354,356
| -3% | -$28.8M | 0.19% | 132 |
|
|
2016
Q2 | $927M | Buy |
11,110,756
+659,835
| +6% | +$58.6M | 0.22% | 117 |
|
|
2016
Q1 | $960M | Sell |
10,450,921
-160,445
| -2% | -$14.5M | 0.23% | 105 |
|
|
2015
Q4 | $1.07B | Buy |
10,611,366
+272,042
| +3% | +$28.3M | 0.25% | 97 |
|
|
2015
Q3 | $1.02B | Buy |
10,339,324
+2,721,362
| +36% | +$302M | 0.25% | 99 |
|
|
2015
Q2 | $892M | Sell |
7,617,962
-215,258
| -3% | -$23.5M | 0.29% | 67 |
|
|
2015
Q1 | $769M | Sell |
7,833,220
-2,632,529
| -25% | -$267M | 0.26% | 79 |
|
|
2014
Q4 | $987M | Sell |
10,465,749
-756,042
| -7% | -$78.2M | 0.35% | 43 |
|
|
2014
Q3 | $1.19B | Sell |
11,221,791
-835,527
| -7% | -$81.8M | 0.39% | 48 |
|
|
2014
Q2 | $1,000M | Sell |
12,057,318
-30,053
| -0.2% | -$2.34M | 0.32% | 60 |
|
|
2014
Q1 | $857M | Buy |
12,087,371
+922,986
| +8% | +$72.4M | 0.32% | 63 |
|
|
2013
Q4 | $838M | Buy |
11,164,385
+2,253,571
| +25% | +$157M | 0.3% | 62 |
|
|
2013
Q3 | $560M | Sell |
8,910,814
-6,619,802
| -43% | -$396M | 0.22% | 91 |
|
|
2013
Q2 | $796M | Buy |
+15,530,616
| New | +$810M | 0.33% | 53 |
|
Other funds holding GILD
VCM
VPM
Bank of America's GILD Position: Q1 2026 in Review
Bank of America reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $440M and leaving 19,978,936 shares worth $2.78B. The position accounts for 0.2% of the portfolio, ranked #98.
Bank of America first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.84B in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bank of America held 19,978,936 shares of Gilead Sciences worth $2.78B as of Q1 2026.
- Bank of America sold 3,142,684 Gilead Sciences shares in Q1 2026, an estimated $440M.
- Gilead Sciences made up 0.2% of Bank of America's portfolio in Q1 2026, its #98 holding.
- Bank of America first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Gilead Sciences position peaked at $2.84B in Q4 2025.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.